Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Consolidated Net Income (2013 - 2026)

Scienture Holdings' (SCNX) quarterly Consolidated Net Income came in at -$2.8 million in Q2 2026, up 58.0% year-over-year from -$1.8 million in Q2 2025, and up 17.31% quarter-over-quarter from -$3.4 million in Q1 2026.

Analysis

Scienture Holdings (SCNX) Consolidated Net Income (2013 - 2026) Analysis & Trends

Scienture Holdings has disclosed Consolidated Net Income across 14 years of filings, most recently posting -$2.8 million for Q2 2026.

  • In Q2 2026, Consolidated Net Income rose 58.0% year-over-year to -$2.8 million; the TTM figure through Jun 2026 stood at -$16.0 million (down 266.4% YoY), while the FY2025 annual figure was -$34.4 million, down 426.51% from the prior year.
  • Consolidated Net Income came in at -$2.8 million for Q2 2026 at Scienture Holdings, up from -$3.4 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $21.2 million in Q1 2024 to a low of -$9.2 million in Q4 2023.
  • Average Consolidated Net Income over 5 years is -$1.2 million, with a median of -$2.3 million recorded in 2022.
  • Year-over-year, Consolidated Net Income tumbled 741.7% in 2023 and jumped 5338.17% in 2024.
  • Over 5 years, Consolidated Net Income stood at -$2.8 million in 2022, then slumped by 233.02% to -$9.2 million in 2023, then surged by 80.09% to -$1.8 million in 2024, then sank by 266.46% to -$6.7 million in 2025, then jumped by 58.0% to -$2.8 million in 2026.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were -$2.8 million in Q2 2026, -$3.4 million in Q1 2026, and -$6.7 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn -576.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn -118.80 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 45.93 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 69.61 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 260.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 24.70 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -66.70 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 30.35 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 1.97 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 -2.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.82 Mn
Mar 31, 2026 -3.41 Mn
Jun 30, 2025 -6.72 Mn
Mar 31, 2025 -3.06 Mn
Jun 30, 2024 -1.83 Mn
Mar 31, 2024 21.25 Mn
Dec 31, 2023 -9.21 Mn
Sep 30, 2023 -4.45 Mn
Jun 30, 2023 -526,359.00
Mar 31, 2023 -405,600.00
Dec 31, 2022 -2.77 Mn
Sep 30, 2022 -528,742.00
Jun 30, 2022 -1.11 Mn
Mar 31, 2022 -981,547.00
Dec 31, 2021 -784,340.00
Sep 30, 2021 -1.30 Mn
Jun 30, 2021 -2.58 Mn
Mar 31, 2021 -651,519.00
Dec 31, 2020 -2.31 Mn
Sep 30, 2020 138,391.00